Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1527-7755

Journal

More filtering options
  1. Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    Zardavas, D., Te Marvelde, L., Milne, R. L., Fumagalli, D., Fountzilas, G., Kotoula, V., Razis, E., Papaxoinis, G., Joensuu, H., Moynahan, M. E., Hennessy, B. T., Bieche, I., Saal, L. H., Stal, O., Iacopetta, B., Jensen, J. D., O'Toole, S., Lopez-Knowles, E., Barbaraeschi, M., Noguchi, S. & 12 others, Azim, H. A., Lerma, E., Bachelot, T., Wang, Q., Perez-Tenorio, G., Can De Velde, C. J. H., Rea, D. W., Sabine, V., Bartlett, J. M. S., Sotiriou, C., Michiels, S. & Loi, S., 2018 Jan 1, In : Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journalArticle

  2. High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk ewing sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

    Whelan, J., Le Deley, M. C., Dirksen, U., Teuff, G. L., Brennan, B., Gaspar, N., Hawkins, D. S., Amler, S., Bauer, S., Bielack, S., Blay, J. Y., Burdach, S., Castex, M. P., Dilloo, D., Eggert, A., Gelderblom, H., Gentet, J. C., Hartmann, W., Hassenpflug, W. A., Hjorth, L. & 23 others, Jimenez, M., Klingebiel, T., Kontny, U., Kruseova, J., Ladenstein, R., Laurence, V., Lervat, C., Marec-Berard, P., Marreaud, S., Michon, J., Morland, B., Paulussen, M., Ranft, A., Reichardt, P., Van Den Berg, H., Wheatley, K., Judson, I., Lewis, I., Craft, A., Juergens, H., Oberlin, O., Euro-E.W.I.N.G.99 & EWING-2008, 2018, In : Journal of Clinical Oncology. 36, 31, p. 3110-3119 10 p.

    Research output: Contribution to journalArticle

  3. Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.

    Wärnberg, F., Garmo, H., Emdin, S., Hedberg, V., Adwall, L., Sandelin, K., Anita Ringberg, Karlsson, P., Arnesson, L-G., Anderson, H., Karin Jirström & Holmberg, L., 2014, In : Journal of Clinical Oncology. 32, 32, p. 3613

    Research output: Contribution to journalArticle

  4. Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication.

    Vickers, A., Cronin, A., Roobol, M., Savage, C., Peltola, M., Pettersson, K., Scardino, P. T., Schröder, F. & Hans Lilja, 2010, In : Journal of Clinical Oncology. May 4, p. 2493-2498

    Research output: Contribution to journalArticle

  5. Development of novel metastatic prostate cancer cell lines by “organoid” in vitro culture technology.

    Vela, I., Gao, D., Gopalan, A., Sboner, A., Eva Undvall, Wanjala, J., Iaquinta, P., Wongvipat, J., Karthaus, W., Clevers, H., Beltran, H., Kossai, M., Mosquera, J. M., Rubin, M. A., Scher, H. I., Sawyers, C. L. & Chen, Y., 2014 Feb 1, In : Journal of Clinical Oncology. 32, 4_suppl, p. 33-33

    Research output: Contribution to journalArticle

  6. Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden.

    Van Hemelrijck, M., Garmo, H., Holmberg, L., Ingelsson, E., Ola Bratt, Bill-Axelson, A., Lambe, M., Stattin, P. & Adolfsson, J., 2010, In : Journal of Clinical Oncology. Jul 1, p. 3448-3456

    Research output: Contribution to journalArticle

  7. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium

    Van Dorp, W., Mulder, R. L., Kremer, L. C. M., Hudson, M. M., Van Den Heuvel-Eibrink, M. M., Van Den Berg, M. H., Levine, J. M., Van Dulmen-Den Broeder, E., Di Iorgi, N., Albanese, A., Armenian, S. H., Bhatia, S., Constine, L. S., Corrias, A., Deans, R., Dirksen, U., Gracia, C. R., Hjorth, L., Kroon, L., Lambalk, C. B. & 13 others, Landier, W., Levitt, G., Leiper, A., Meacham, L., Mussa, A., Neggers, S. J., Oeffinger, K. C., Revelli, A., Van Santen, H. M., Skinner, R., Toogood, A., Wallace, W. H. & Haupt, R., 2016 Oct 1, In : Journal of Clinical Oncology. 34, 28, p. 3440-3450 11 p.

    Research output: Contribution to journalReview article

  8. Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.

    Tveit, K. M., Guren, T., Glimelius, B., Pfeiffer, P., Sorbye, H., Pyrhonen, S., Sigurdsson, F., Kure, E., Ikdahl, T., Skovlund, E., Fokstuen, T., Hansen, F., Hofsli, E., Birkemeyer, E., Johnsson, A., Starkhammar, H., Yilmaz, M. K., Keldsen, N., Erdal, A. B., Dajani, O. & 2 others, Dahl, O. & Christoffersen, T., 2012, In : Journal of Clinical Oncology. 30, 15, p. 1755-1762

    Research output: Contribution to journalArticle

  9. Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study.

    Ingemar Turesson, Velez, R., Kristinsson, S. Y. & Landgren, O., 2010, In : Journal of Clinical Oncology. 28, p. 830-834

    Research output: Contribution to journalArticle

  10. Models of care for survivors of childhood cancer from across the globe: Advancing survivorship care in the next decade

    Tonorezos, E. S., Barnea, D., Cohn, R. J., Cypriano, M. S., Fresneau, B. C., Haupt, R., Lars Hjorth, Ishida, Y., Kruseova, J., Kuehni, C. E., Kurkure, P. A., Langer, T., Nathan, P. C., Skeen, J. E., Skinner, R., Tacyildiz, N., Van Den Heuvel-Eibrink, M. M., Winther, J. F., Hudson, M. M. & Oeffinger, K. C., 2018 Jul 20, In : Journal of Clinical Oncology. 36, 21, p. 2223-2230 8 p.

    Research output: Contribution to journalReview article

  11. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors

    Timmerman, D., Van Calster, B., Jurkovic, D., Lil Valentin, Testa, A. C., Bernard, J-P., Van Holsbeke, C., Van Huffel, S., Vergote, I. & Bourne, T., 2007, In : Journal of Clinical Oncology. 25, 27, p. 4194-4200

    Research output: Contribution to journalArticle

  12. Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses - Reply

    Timmerman, D., Bourne, T., Amant, F., Van Holsbeke, C., Vergote, I., Testa, A. C., Van Calster, B., Van Huffel, S. & Lil Valentin, 2008, In : Journal of Clinical Oncology. 26, 3, p. 513-513

    Research output: Contribution to journalLetter

  13. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: A multicenter study by the International Ovarian Tumor Analysis Group

    Timmerman, D., Testa, AC., Bourne, T., Ferrazzi, E., Ameye, L., Konstantinovic, ML., Van Calster, B., Collins, WP., Vergote, I., Van Huffel, S. & Lil Valentin, 2005, In : Journal of Clinical Oncology. 23, 34, p. 8794-8801

    Research output: Contribution to journalArticle

  14. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.

    Terpos, E., Morgan, G., Dimopoulos, M. A., Drake, M. T., Lentzsch, S., Raje, N., Sezer, O., García-Sanz, R., Shimizu, K., Ingemar Turesson, Reiman, T., Jurczyszyn, A., Merlini, G., Spencer, A., Leleu, X., Cavo, M., Munshi, N., Rajkumar, S. V., Durie, B. G. M. & Roodman, G. D., 2013, In : Journal of Clinical Oncology. 31, 18, p. 2347-U179

    Research output: Contribution to journalArticle

  15. Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

    Tanner, M., Isola, J., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2006, In : Journal of Clinical Oncology. 24, 16, p. 2428-2436

    Research output: Contribution to journalArticle

  16. Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

    Tanner, MM., Isola, JJ., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2005, In : Journal of Clinical Oncology. 23, 16S, p. 841S-841S

    Research output: Contribution to journalPublished meeting abstract

  17. Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA).

    Tandstad, T., Smaaland, R., Solberg, A., Bremnes, R. M., Langberg, C. W., Laurell, A., Stierner, U. K., Ståhl, O., Cavallin-Ståhl, E., Klepp, O. H., Dahl, O. & Cohn-Cedermark, G., 2011, In : Journal of Clinical Oncology. 29, 4, p. 719-725

    Research output: Contribution to journalArticle

  18. Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program.

    Tandstad, T., Dahl, O., Cohn-Cedermark, G., Cavallin-Ståhl, E., Stierner, U., Solberg, A., Langberg, C., Bremnes, R. M., Laurell, A., Wijkstrøm, H. & Klepp, O., 2009, In : Journal of Clinical Oncology. 27, p. 2122-2128

    Research output: Contribution to journalArticle

  19. Risk of second cancer in Hodgkin lymphoma survivors and influence of family history

    Sud, A., Hauke Thomsen, Kristina Sundquist, Houlston, R. S. & Kari Hemminki, 2017 May 10, In : Journal of Clinical Oncology. 35, 14, p. 1584-1590 7 p.

    Research output: Contribution to journalArticle

  20. Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer

    Sternberg, C., Armstrong, A., Pili, R., Ng, S., Huddart, R., Agarwal, N., Khvorostenko, D., Lyulko, O., Brize, A., Vogelzang, N., Delva, R., Harza, M., Thanos, A., James, N., Werbrouck, P., Bögemann, M., Hutson, T., Milecki, P., Chowdhury, S., Gallardo, E. & 6 others, Schwartsmann, G., Pouget, J. C., Baton, F., Nederman, T., Tuvesson, H. & Carducci, M., 2016 Aug 1, In : Journal of Clinical Oncology. 34, 22, p. 2636-2643 8 p.

    Research output: Contribution to journalArticle

  21. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition

    Stephenson, A. J., Kattan, M. W., Eastham, J. A., Dotan, Z. A., Bianco, F. J. J., Hans Lilja & Scardino, P. T., 2006, In : Journal of Clinical Oncology. 24, 24, p. 3973-3978

    Research output: Contribution to journalArticle

  22. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome

    Skotheim, RI., Kallioniemi, A., Bjerkhagen, B., Fredrik Mertens, Brekke, HR., Monni, O., Mousses, S., Mandahl, N., Saeter, G., Nesland, JM., Smeland, S., Kallioniemi, OP. & Lothe, RA., 2003, In : Journal of Clinical Oncology. 21, 24, p. 4586-4591

    Research output: Contribution to journalArticle

  23. Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden.

    Sjövall, K., Attner, B., Lithman, T., Noreen, D., Gunnars, B., Thomé, B. & Håkan Olsson, 2009, In : Journal of Clinical Oncology. 27, p. 4781-4786

    Research output: Contribution to journalArticle

  24. Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial

    Martin Sjöström, Lundstedt, D., Linda Hartman, Holmberg, E., Killander, F., Kovács, A., Per Malmström, Emma Niméus, Rönnerman, E. W., Mårten Fernö & Karlsson, P., 2017 Oct 1, In : Journal of Clinical Oncology. 35, 28, p. 3222-3229 8 p.

    Research output: Contribution to journalArticle

  25. 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial.

    Scholz, C. W., Pinto, A., Linkesch, W., Lindén, O., Viardot, A., Keller, U., Hess, G., Lastoria, S., Lerch, K., Frigeri, F., Arcamone, M., Stroux, A., Frericks, B., Pott, C. & Pezzutto, A., 2013, In : Journal of Clinical Oncology. 31, 3, p. 308-313

    Research output: Contribution to journalArticle

  26. Emergence of New ALK Mutations at Relapse of Neuroblastoma.

    Schleiermacher, G., Javanmardi, N., Bernard, V., Leroy, Q., Cappo, J., Rio Frio, T., Pierron, G., Lapouble, E., Combaret, V., Speleman, F., de Wilde, B., Djos, A., Øra, I., Hedborg, F., Träger, C., Holmqvist, B-M., Abrahamsson, J., Peuchmaur, M., Michon, J., Janoueix-Lerosey, I. & 3 others, Kogner, P., Delattre, O. & Martinsson, T., 2014, In : Journal of Clinical Oncology. 32, 25, p. 2727

    Research output: Contribution to journalArticle

  27. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: Role of allogeneic stem-cell transplantation in Nordic data

    Saarinen-Pihkala, U. M., Heilmann, C., Winiarski, J., Glomstein, A., Abrahamsson, J., Arvidson, J., Békássy, A., Forestier, E., Jonmundsson, G., Schroeder, H., Vettenranta, K., Wesenberg, F. & Gustafsson, G., 2006, In : Journal of Clinical Oncology. 24, 36, p. 5750-5762

    Research output: Contribution to journalArticle

  28. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma

    A. Rydholm, P. Gustafson, Rooser, B., Willen, H., Akerman, M., Herrlin, K. & T. Alvegard, 1991 Jan 1, In : Journal of Clinical Oncology. 9, 10, p. 1757-1765 9 p.

    Research output: Contribution to journalArticle

  29. t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

    Roulland, S., Kelly, R. S., Morgado, E., Sungalee, S., Solal-Celigny, P., Colombat, P., Jouve, N., Palli, D., Pala, V., Tumino, R., Panico, S., Sacerdote, C., Quiros, J. R., Gonzales, C. A., Sanchez, M-J., Dorronsoro, M., Navarro, C., Barricarte, A., Tjonneland, A., Olsen, A. & 29 others, Overvad, K., Canzian, F., Kaaks, R., Boeing, H., Drogan, D., Nieters, A., Clavel-Chapelon, F., Trichopoulou, A., Trichopoulos, D., Lagiou, P., Bueno-de-Mesquita, H. B., Peeters, P. H. M., Vermeulen, R., Hallmans, G., Melin, B., Signe Borgquist, Joyce Carlson, Lund, E., Weiderpass, E., Khaw, K-T., Wareham, N., Key, T. J., Travis, R. C., Ferrari, P., Romieu, I., Riboli, E., Salles, G., Vineis, P. & Nadel, B., 2014, In : Journal of Clinical Oncology. 32, 13, p. 1347

    Research output: Contribution to journalArticle

  30. Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?

    Johan Richter, Söderlund, S., Lübking, A., Dreimane, A., Lotfi, K., Markevärn, B., Själander, A., Saussele, S., Olsson-Strömberg, U. & Stenke, L., 2014, In : Journal of Clinical Oncology. 32, 25, p. 2821-2823

    Research output: Contribution to journalLetter

  31. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer

    Renkonen, E., Zhang, YG., Lohi, H., Salovaara, R., Abdel-Rahman, WM., Mef Nilbert, Aittomaki, K., Jarvinen, HJ., Mecklin, JP., Lindblom, A. & Peltomaki, P., 2003, In : Journal of Clinical Oncology. 21, 19, p. 3629-3637

    Research output: Contribution to journalArticle

  32. Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study

    Kajsa Paulsson & Ponte di Legno Childhood ALL Working Group, 2019 Apr 1, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 10, p. 770-779 10 p.

    Research output: Contribution to journalArticle

  33. Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.

    Poplin, E., Wasan, H., Rolfe, L., Raponi, M., Ikdahl, T., Bondarenko, I., Davidenko, I., Bondar, V., Garin, A., Boeck, S., Ormanns, S., Heinemann, V., Bassi, C., Evans, T. R. J., Andersson, R., Hahn, H., Picozzi, V., Dicker, A., Mann, E., Voong, C. & 3 others, Kaur, P., Isaacson, J. & Allen, A., 2013, In : Journal of Clinical Oncology. 31, 35, p. 4453-4461

    Research output: Contribution to journalArticle

  34. Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

    Phillips, K-A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C., Peock, S., Frost, D., Easton, D. F., Ellis, S., Friedlander, M. L., Buys, S. S., Andrieu, N., Noguès, C., Stoppa-Lyonnet, D., Bonadona, V., Pujol, P., McLachlan, S. A., John, E. M., Hooning, M. J., Seynaeve, C. & 16 others, Tollenaar, R. A. E. M., Goldgar, D. E., Terry, M. B., Caldes, T., Weideman, P. C., Andrulis, I. L., Singer, C. F., Birch, K., Simard, J., Southey, M. C., Håkan Olsson, Jakubowska, A., Olah, E., Gerdes, A-M., Foretova, L. & Hopper, J. L., 2013, In : Journal of Clinical Oncology. 31, 25, p. 3091

    Research output: Contribution to journalArticle

  35. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis

    Petersen, P. M., Aleksander Giwercman, Daugaard, G., Rorth, M., Petersen, J. H., Skakkeaek, N. E., Hansen, S. W. & von der Maase, H., 2002, In : Journal of Clinical Oncology. 20, 6, p. 1537

    Research output: Contribution to journalArticle

  36. Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA

    Olofsson, S., Dahl, O., Mats Jerkeman, Cohn-Cedermark, G., Klepp, O., Stierner, U., Tornblom, M., Wahlqvist, R. & Cavallin-Ståhl, E., 2009, In : Journal of Clinical Oncology. 27, 15

    Research output: Contribution to journalPublished meeting abstract

  37. Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group.

    Olofsson, S-E., Tandstad, T., Mats Jerkeman, Dahl, O., Ståhl, O., Klepp, O., Bremnes, R. M., Cohn-Cedermark, G., Langberg, C. W., Laurell, A., Solberg, A., Stierner, U., Wahlqvist, R., Wijkström, H., Anderson, H. & Cavallin-Ståhl, E., 2011, In : Journal of Clinical Oncology. 29, p. 2032-2039

    Research output: Contribution to journalArticle

  38. Role for Genetic Anticipation in Lynch Syndrome.

    Mef Nilbert, Timshel, S., Bernstein, I. & Larsen, K., 2009, In : Journal of Clinical Oncology. 27, p. 360-364

    Research output: Contribution to journalArticle

  39. Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

    Nielsen, D. L., Bjerre, K. D., Jakobsen, E. H., Cold, S., Stenbygaard, L., Sørensen, P. G., Kamby, C., Møller, S., Charlotte Levin Tykjaer Jörgensen & Andersson, M., 2011, In : Journal of Clinical Oncology. 29, 36, p. 4748-4754

    Research output: Contribution to journalArticle

  40. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries

    Möller, T. R., Garwicz, S., Barlow, L., Falck Winther, J., Glattre, E., Olafsdottir, G., Olsen, J. H., Perfekt, R., Ritvanen, A., Sankila, R. & Tulinius, H., 2001, In : Journal of Clinical Oncology. 19, 13, p. 3173-3181

    Research output: Contribution to journalArticle

  41. Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer

    Mellby, L. D., Nyberg, A. P., Johansen, J. S., Christer Wingren, Nordestgaard, B. G., Bojesen, S. E., Mitchell, B. L., Sheppard, B. C., Sears, R. C. & Carl A.K. Borrebaeck, 2018, In : Journal of Clinical Oncology. 36, 28, p. 2887-2894 8 p.

    Research output: Contribution to journalArticle

  42. Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.

    Olle Melander, Marju Orho-Melander, Jonas Manjer, Svensson, T., Almgren, P., Peter Nilsson, Gunnar Engström, Bo Hedblad, Signe Borgquist, Hartmann, O., Struck, J., Bergmann, A. & Mattias Belting, 2015, In : Journal of Clinical Oncology. 33, 24, p. 2632-U81

    Research output: Contribution to journalArticle

  43. Immunotherapy for Glioblastoma: The Devil Is in the Details Reply

    Mehta, A. I., Persson, O., Herndon, J. E. . II., Archer, G. E., McLendon, R., Heimberger, A. B., Mitchell, D. A., Bigner, D. D. & Sampson, J. H., 2011, In : Journal of Clinical Oncology. 29, 22, p. 3105-3106

    Research output: Contribution to journalLetter

  44. International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

    Maurer, M. J., Fredrik Ellin, Srour, L., Mats Jerkeman, Bennani, N. N., Connors, J. M., Slack, G. W., Smedby, K. E., Ansell, S. M., Link, B. K., Cerhan, J. R., Relander, T., Savage, K. J. & Feldman, A. L., 2017 Dec 20, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 36, p. 4019-4026 8 p.

    Research output: Contribution to journalArticle

  45. Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.

    Malone, K. E., Begg, C. B., Haile, R. W., Åke Borg, Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., Reiner, A. S., Riedel, E. R., Thomas, D. C., Mellemkjær, L., Lynch, C. F., Boice, J. D., Anton-Culver, H. & Bernstein, J. L., 2010, In : Journal of Clinical Oncology. 28, p. 2404-2410

    Research output: Contribution to journalArticle

Previous 1 2 3 Next